Overall, our findings demonstrated that the optoenergetic activation of mt-EcGAPR rescued mitochondrial hypometabolism, alleviated the ER stress–ATF6 axis, and inhibited pyroptosis, leading to enhanced neuroprotective effects against glaucoma (Fig. 5j). Here, ATF6 is linked to glaucoma.